Edut02-00 (Edut02 00)
Dutasteride Capsule, Liquid Filled
Product Images NDC 42806-549
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Dutasteride (NDC 42806-549). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Epic Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure-1 (Figure 1)
Figure-2 (Figure 2)
This appears to be a chart that shows the number of patients at risk and the number of events cumulatively over a certain period of time during treatment. The chart displays two groups, one named "Placetio Grulp" and the other "Dutasteride Group", with the number of events and number of patients at risk for each group shown for each month of treatment over a 24 month period. There is additional text at the top that appears to indicate the scale for the percent of patients which is not visible in the provided text.*
Figure-3 (Figure 3)
Figure-4 (Figure 4)
Figure-5 (Figure 5)
This appears to be a graph or chart displaying the Mean Change From Baseline (measured in mL/sec) over the course of 24 months for two different treatments: Placebo and Dutasteride. The x-axis represents the months of treatment while the y-axis represents the mean change in mL/sec. The number of subjects (n) for each treatment is also provided for each time point.*
Figure-6 (Figure 6)
Figure-7 (Figure 7)
Not available.*
Structural-formula (Image 01)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
